X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare J.B.Chemicals with AJANTA PHARMA - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

J.B.CHEMICALS vs AJANTA PHARMA - Comparison Results

J.B.CHEMICALS    Change

JB Chemicals and Pharmaceuticals Limited (JBCPL), the flagship of the Unique Group, is one of the India's leading transnational pharmaceutical company. The company has 11 manufacturing facilities at four locations in India (Belapur, Ankleshwar, Panol... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    J.B.CHEMICALS AJANTA PHARMA J.B.CHEMICALS/
AJANTA PHARMA
 
P/E (TTM) x 17.5 23.6 74.2% View Chart
P/BV x 2.2 4.5 49.4% View Chart
Dividend Yield % 0.5 0.0 -  

Financials

 J.B.CHEMICALS   AJANTA PHARMA
EQUITY SHARE DATA
    J.B.CHEMICALS
Mar-18
AJANTA PHARMA
Mar-18
J.B.CHEMICALS/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3631,818 20.0%   
Low Rs2551,106 23.1%   
Sales per share (Unadj.) Rs169.1239.5 70.6%  
Earnings per share (Unadj.) Rs16.652.8 31.4%  
Cash flow per share (Unadj.) Rs23.459.5 39.4%  
Dividends per share (Unadj.) Rs2.000-  
Dividend yield (eoy) %0.60-  
Book value per share (Unadj.) Rs172.5230.0 75.0%  
Shares outstanding (eoy) m83.5788.77 94.1%   
Bonus/Rights/Conversions BB--  
Price / Sales ratio x1.86.1 29.9%   
Avg P/E ratio x18.627.7 67.2%  
P/CF ratio (eoy) x13.224.6 53.7%  
Price / Book Value ratio x1.86.4 28.2%  
Dividend payout %12.00-   
Avg Mkt Cap Rs m25,827129,782 19.9%   
No. of employees `0003.86.8 55.5%   
Total wages/salary Rs m2,5113,765 66.7%   
Avg. sales/employee Rs Th3,747.43,128.4 119.8%   
Avg. wages/employee Rs Th665.7554.0 120.2%   
Avg. net profit/employee Rs Th367.8689.7 53.3%   
INCOME DATA
Net Sales Rs m14,13521,258 66.5%  
Other income Rs m366242 151.4%   
Total revenues Rs m14,50121,499 67.4%   
Gross profit Rs m2,1786,584 33.1%  
Depreciation Rs m570596 95.6%   
Interest Rs m354 851.2%   
Profit before tax Rs m1,9406,226 31.2%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m5521,539 35.9%   
Profit after tax Rs m1,3874,686 29.6%  
Gross profit margin %15.431.0 49.8%  
Effective tax rate %28.524.7 115.2%   
Net profit margin %9.822.0 44.5%  
BALANCE SHEET DATA
Current assets Rs m10,47012,236 85.6%   
Current liabilities Rs m2,7493,461 79.4%   
Net working cap to sales %54.641.3 132.3%  
Current ratio x3.83.5 107.7%  
Inventory Days Days5560 91.7%  
Debtors Days Days7884 91.9%  
Net fixed assets Rs m5,81111,140 52.2%   
Share capital Rs m167177 94.5%   
"Free" reserves Rs m14,24820,237 70.4%   
Net worth Rs m14,41620,414 70.6%   
Long term debt Rs m010 0.0%   
Total assets Rs m17,64924,486 72.1%  
Interest coverage x56.61,519.4 3.7%   
Debt to equity ratio x00 0.0%  
Sales to assets ratio x0.80.9 92.3%   
Return on assets %8.119.2 42.1%  
Return on equity %9.623.0 41.9%  
Return on capital %13.730.5 44.9%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m6,16411,667 52.8%   
Fx outflow Rs m1,3341,616 82.6%   
Net fx Rs m4,82910,052 48.0%   
CASH FLOW
From Operations Rs m1,2312,854 43.1%  
From Investments Rs m-208-2,604 8.0%  
From Financial Activity Rs m-595-2 29,760.0%  
Net Cashflow Rs m427248 172.1%  

Share Holding

Indian Promoters % 55.4 73.8 75.1%  
Foreign collaborators % 0.3 0.0 -  
Indian inst/Mut Fund % 3.4 1.6 218.7%  
FIIs % 3.9 7.6 51.3%  
ADR/GDR % 0.0 0.0 -  
Free float % 37.0 17.0 217.6%  
Shareholders   30,437 20,968 145.2%  
Pledged promoter(s) holding % 0.0 4.4 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare J.B.CHEMICALS With:   PFIZER  GSK PHARMA  PANACEA BIOTECH  WYETH LTD  ABBOTT INDIA  

Compare J.B.CHEMICALS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Modi's Victory Creates Sensex History; Ache Din Ahead?(Podcast)

Throughout the week, one slogan that took over the market and country as a whole was, Ab ki baar phir Modi Sarkar.

Related Views on News

J.B.CHEMICALS Announces Quarterly Results (4QFY19); Net Profit Up 91.2% (Quarterly Result Update)

May 24, 2019 | Updated on May 24, 2019

For the quarter ended March 2019, J.B.CHEMICALS has posted a net profit of Rs 422 m (up 91.2% YoY). Sales on the other hand came in at Rs 4 bn (up 18.9% YoY). Read on for a complete analysis of J.B.CHEMICALS's quarterly results.

AJANTA PHARMA Announces Quarterly Results (4QFY19); Net Profit Down 5.9% (Quarterly Result Update)

May 3, 2019 | Updated on May 3, 2019

For the quarter ended March 2019, AJANTA PHARMA has posted a net profit of Rs 889 m (down 5.9% YoY). Sales on the other hand came in at Rs 5 bn (down 2.9% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

J.B.CHEMICALS 2017-18 Annual Report Analysis (Annual Result Update)

Mar 28, 2019 | Updated on Mar 28, 2019

Here's an analysis of the annual report of J.B.CHEMICALS for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of J.B.CHEMICALS. Also includes updates on the valuation of J.B.CHEMICALS.

AJANTA PHARMA Announces Quarterly Results (3QFY19); Net Profit Down 54.6% (Quarterly Result Update)

Feb 1, 2019 | Updated on Feb 1, 2019

For the quarter ended December 2018, AJANTA PHARMA has posted a net profit of Rs 669 m (down 54.6% YoY). Sales on the other hand came in at Rs 5 bn (down 17.4% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

AJANTA PHARMA Announces Quarterly Results (2QFY19); Net Profit Down 4.9% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, AJANTA PHARMA has posted a net profit of Rs 1 bn (down 4.9% YoY). Sales on the other hand came in at Rs 5 bn (up 0.7% YoY). Read on for a complete analysis of AJANTA PHARMA's quarterly results.

More Views on News

Most Popular

My Top 7 Stocks to Profit from Sensex 100,000(The 5 Minute Wrapup)

May 16, 2019

Tanushree Banerjee explains everything you need to know about the Rebirth of India and Sensex 100,000.

3 Stocks to Bet on to Become a 'Dividend Millionaire'(Profit Hunter)

May 14, 2019

As markets continue to rattle amid earning season, upcoming elections, volatile crude price and US China trade war, it's a great idea to add some stability to your portfolio by adding dividend stocks.

Indian Steel: The Perfect Multibagger Opportunity(Profit Hunter)

May 17, 2019

A structurally strong Indian Steel Industry will help India achieve 8%+ GDP growth in the coming years.

What Makes TVS Srichakra and CCL Products a Cut Above the Rest?(The 5 Minute Wrapup)

May 17, 2019

Despite the commodity nature of their businesses, these two stocks have rewarded shareholders well.

The Bitter Pill that Will Lay the Foundation for Sensex 100,000(The 5 Minute Wrapup)

May 14, 2019

These companies will help the Sensex more than double from current levels.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

J.B.CHEMICALS SHARE PRICE


May 24, 2019 (Close)

TRACK J.B.CHEMICALS

  • Track your investment in J.B.CHEMICALS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

J.B.CHEMICALS - FULFORD INDIA COMPARISON

COMPARE J.B.CHEMICALS WITH

MARKET STATS